EUVIMEDOtkrijte EUVIMED
Open access · CC BY 4.0

Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study

David Rekhtman iD, Amit Iyengar, Cindy Song iD, Michaela Asher, Max Shin iD, Michael Catalano iD, Omar Toubat, Emma Morganroth, Alyson Brown, Joyce Wald, Aditya Parikh, Mauer Biscotti and 1 more

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70452 ↗

At a glance

Journal article in Clinical Transplantation, 2026. Written by David Rekhtman and 12 co-authors. Institution: Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Heart Transplantation, Heart-Assist Devices, Postoperative Complications, Graft Rejection. Cited 1 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0).

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Objectives

Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post‐transplant outcomes. This study aims to compare post‐transplantation outcomes based on duration of support with the Impella 5.5.

Methods

All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1‐year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year.

Results

Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1‐year survival was 96% and similar between the two cohorts ( p = 0.289).

Conclusions

Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post‐transplant outcomes for patients stratified by support duration.

Subjects

MeSH terms (MEDLINE)

Heart TransplantationHeart-Assist DevicesPostoperative ComplicationsGraft RejectionHeart FailureShock, CardiogenicHumansFemaleMaleFollow-Up StudiesMiddle AgedSurvival RatePrognosisGraft SurvivalRetrospective StudiesRisk FactorsTime FactorsLength of StayBridge Therapy

Author keywords

heart failureheart transplantationtemporary mechanical circulatory support

Authors and institutions

  • Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID profiles: David Rekhtman, Cindy Song, Max Shin, Michael Catalano

Cite

APA

Rekhtman, D., Iyengar, A., Song, C., Asher, M., Shin, M., Catalano, M., Toubat, O., Morganroth, E., Brown, A., Wald, J., Parikh, A., Biscotti, M., & Cevasco, M. (2026). Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70452

Vancouver

Rekhtman D, Iyengar A, Song C, Asher M, Shin M, Catalano M, et al. Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study. Clinical Transplantation. 2026. doi:10.1111/ctr.70452

BibTeX
@article{Rekhtman2026,
  author = {Rekhtman, David and Iyengar, Amit and Song, Cindy and Asher, Michaela and Shin, Max and Catalano, Michael and Toubat, Omar and Morganroth, Emma and Brown, Alyson and Wald, Joyce and Parikh, Aditya and Biscotti, Mauer and Cevasco, Marisa},
  title = {Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70452}
}
Start for free →